iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 3,799 shares, a decrease of 40.0% from the January 15th total of 6,335 shares. Approximately 1.2% of the company’s stock are short sold. Based on an average daily trading volume, of 11,722 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily trading volume, of 11,722 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.2% of the company’s stock are short sold.

iShares Health Innovation Active ETF Stock Up 0.4%

Shares of NYSEARCA:BMED traded up $0.13 on Friday, reaching $30.48. 1,533 shares of the company’s stock were exchanged, compared to its average volume of 7,568. The business’s 50-day moving average is $30.84 and its two-hundred day moving average is $28.56. iShares Health Innovation Active ETF has a fifty-two week low of $20.57 and a fifty-two week high of $32.19. The firm has a market capitalization of $9.75 million, a price-to-earnings ratio of 24.91 and a beta of 0.84.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.